Seraphina Therapeutics
Founded 2017 · 14 employees on LinkedIn · 2 known investors
Find your way into Seraphina Therapeutics
94 people in our graph share verified history with the Seraphina Therapeutics team — schools, employers, funds. One of them is your warm intro.
Ann Crady Weissunlockedknows Stephanie Venn-Watson · together at UC San Diego (overlapped)
×5knows the team · via UC San Diego
×6knows the team · via Defense Advanced Research Projects Agency (DARPA)
Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age. The company focuses on evidence-based nutritional science for consumer wellness.
Founders & leadership
Seraphina Therapeutics was founded in 2017 by Stephanie Venn-Watson.
SV
Stephanie Venn-WatsoninCo-Founder, Co-CEOStephanie Venn-Watson is a veterinary epidemiologist who has held research and leadership positions at the National Marine Mammal Foundation, DARPA, the Centers for Disease Control and Prevention, and the World Health Organization. She is co-founder and co-CEO of Seraphina Therapeutics, which develops nutritional products based on metabolomics research, and co-founder of Epitracker, a life sciences research organization.
Investors · 2
In the news
Frequently asked questions
- What does Seraphina Therapeutics do?
- Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age. The company focuses on evidence-based nutritional science for consumer wellness.
- Who founded Seraphina Therapeutics?
- Seraphina Therapeutics was founded by Stephanie Venn-Watson in 2017.
- Who are Seraphina Therapeutics's investors?
- Seraphina Therapeutics's investors include 1315 Capital, BioBrit.